Total Payments
$13,926
2024 Payments
$615.98
Companies
42
Transactions
338
Medicare Patients
4,143
Medicare Billing
$359,403
Payment Breakdown by Category
Research$7,715 (55.4%)
Food & Beverage$5,918 (42.5%)
Education$293.16 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,715 | 10 | 55.4% |
| Food and Beverage | $5,918 | 323 | 42.5% |
| Education | $293.16 | 5 | 2.1% |
Payments by Type
Research
$7,715
10 transactions
General
$6,211
328 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $9,080 | 107 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,640 | 72 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $440.09 | 27 | $0 (2024) |
| GENZYME CORPORATION | $271.94 | 12 | $0 (2023) |
| Insmed, Inc. | $265.16 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $228.87 | 9 | $0 (2024) |
| Mylan Specialty L.P. | $164.61 | 9 | $0 (2024) |
| Boston Scientific Corporation | $144.69 | 3 | $0 (2019) |
| HARMONY BIOSCIENCES LLC | $128.73 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $126.71 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $615.98 | 34 | AstraZeneca Pharmaceuticals LP ($165.59) |
| 2023 | $865.62 | 42 | GENZYME CORPORATION ($208.94) |
| 2022 | $854.89 | 35 | AstraZeneca Pharmaceuticals LP ($380.52) |
| 2021 | $676.38 | 31 | AstraZeneca Pharmaceuticals LP ($375.59) |
| 2020 | $603.23 | 41 | GlaxoSmithKline, LLC. ($162.75) |
| 2019 | $1,500 | 79 | GlaxoSmithKline, LLC. ($518.09) |
| 2018 | $897.06 | 63 | GlaxoSmithKline, LLC. ($296.20) |
| 2017 | $7,913 | 13 | GlaxoSmithKline, LLC. ($7,749) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: PULMONOLOGY | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.46 | General |
| Category: Narcoplepsy | ||||||
| 08/27/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Inflammation | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Respiratory | ||||||
| 07/30/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Pulmonology | ||||||
| 07/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: RESPIRATORY | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 04/30/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Pulmonology | ||||||
| 04/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological), TEZSPIRE | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Study HZA114971, A Multicentre Randomised, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Effects of a One Year Regimen of Orally Inhaled Fluticasone Furoate 50 mcg once daily on Growth Velocity in Prepubertal, Paediatric Subjects | GlaxoSmithKline, LLC. | $7,715 | 10 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,087 | 1,441 | $242,389 | $95,643 |
| 2022 | 17 | 1,093 | 1,454 | $246,162 | $98,831 |
| 2021 | 15 | 935 | 1,204 | $187,041 | $82,194 |
| 2020 | 22 | 1,028 | 1,348 | $223,847 | $82,736 |
Total Patients
4,143
Total Services
5,447
Medicare Billing
$359,403
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 303 | 509 | $79,913 | $43,813 | 54.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 229 | $24,045 | $13,380 | 55.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 84 | 84 | $26,124 | $12,331 | 47.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 61 | $15,799 | $7,950 | 50.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 64 | $9,664 | $3,769 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $7,020 | $3,579 | 51.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 141 | 158 | $16,116 | $2,725 | 16.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 25 | $6,595 | $2,239 | 34.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $5,865 | $2,049 | 34.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 19 | 19 | $10,507 | $1,189 | 11.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 29 | 41 | $5,658 | $678.80 | 12.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 61 | 61 | $7,137 | $552.05 | 7.7% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 15 | 15 | $10,500 | $510.35 | 4.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 61 | 61 | $9,028 | $471.53 | 5.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 61 | 61 | $8,418 | $407.48 | 4.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 267 | 479 | $72,359 | $41,697 | 57.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 194 | 258 | $26,028 | $15,213 | 58.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 84 | 84 | $25,098 | $13,046 | 52.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 49 | $12,196 | $6,273 | 51.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $9,137 | $5,502 | 60.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 139 | 164 | $16,092 | $3,077 | 19.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $7,675 | $2,958 | 38.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 32 | $8,105 | $2,530 | 31.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $5,230 | $2,343 | 44.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 35 | $5,042 | $1,816 | 36.0% |
About Dr. Eric Trueblood, M.D
Dr. Eric Trueblood, M.D is a Critical Care Medicine healthcare provider based in Bloomington, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215924675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Trueblood, M.D has received a total of $13,926 in payments from pharmaceutical and medical device companies, with $615.98 received in 2024. These payments were reported across 338 transactions from 42 companies. The most common payment nature is "" ($7,715).
As a Medicare-enrolled provider, Trueblood has provided services to 4,143 Medicare beneficiaries, totaling 5,447 services with total Medicare billing of $359,403. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Bloomington, IN
- Active Since 09/30/2005
- Last Updated 11/02/2016
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1215924675
Products in Payments
- VERAMYST (Drug) $7,715
- TRELEGY ELLIPTA (Drug) $575.87
- NUCALA (Biological) $530.66
- DUPIXENT (Biological) $500.81
- BREZTRI (Drug) $408.12
- SYMBICORT (Drug) $296.13
- FASENRA (Biological) $274.77
- OFEV (Drug) $273.93
- Arikayce (Drug) $248.92
- FASENRA (Drug) $230.78
- TEZSPIRE (Biological) $214.98
- GLASSIA (Biological) $205.66
- Yupelri (Drug) $134.38
- WAKIX (Drug) $128.73
- ANORO (Drug) $121.85
- WATCHMAN (Device) $114.83
- OPSUMIT (Drug) $105.78
- NUEDEXTA (Drug) $87.64
- STIOLTO RESPIMAT (Drug) $84.47
- Cook Medical Centesis & Drainage (Device) $76.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Bloomington
Rajeev Varma, Md, MD
Critical Care Medicine — Payments: $7,713
Critical Care Medicine $7,713
Karen Sayad, Md, MD
Critical Care Medicine — Payments: $6,830
Critical Care Medicine $6,830
Helen Kirk, M.d, M.D
Critical Care Medicine — Payments: $856.21
Critical Care Medicine $856.21
Dr. Carlos Silva, Md, MD
Critical Care Medicine — Payments: $626.71
Critical Care Medicine $626.71
Yaser Abu El-Sameed, M.d, M.D
Critical Care Medicine — Payments: $127.14
Critical Care Medicine $127.14
Vincent Holly, Rn, Aprn, Cns, RN, APRN, CNS
Critical Care Medicine — Payments: $68.55
Critical Care Medicine $68.55